MXPA03000861A - Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. - Google Patents
Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo.Info
- Publication number
- MXPA03000861A MXPA03000861A MXPA03000861A MXPA03000861A MXPA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A MX PA03000861 A MXPA03000861 A MX PA03000861A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- general formula
- dementia
- group
- aryl
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical class 0.000 abstract 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 208000020358 Learning disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 208000013677 cerebrovascular dementia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 201000003723 learning disability Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Medicinas para el tratamiento o la prevencion de demencia, que contienen como ingrediente activo derivados de 2-aril-8-oxodihidropurina de la formula general (I) o sales de adicion acido de los mismos aceptables farmaceuticamente: (I) [en donde W es H, alquilo de C1-6, halogeno, alcoxi de C1-6, o los similares; X es H, alquilo de C1-6, un grupo de la formula general (Q): -CH(R3) CON (R1) (R2) (en donde R1 es alquilo de C1-6 o los similares; R2 es alquilo de C1-4 substituido con fenilo o los similares; y R3 es H o los similares), o los similares; Y es H, alquilo de C1-6, un grupo de la formula general (Q) anterior, o los similares; y A es fenilo substituido o los similares, con la condicion de que uno de X e Y sea un grupo de la formula general (Q) y el otro sea un grupo seleccionado de entre los descritos anteriormente para X e Y excepto los de la formula general (Q))]. Los compuestos anteriores exhiben un efecto mejorador extremadamente potente sobre trastornos del aprendizaje y/o trastornos de la memoria y asi son utiles en el tratamiento o la prevencion de demencia del tipo Alzheimer, demencia cerebrovascular, demencia senil, y asi sucesivamente. (ver formula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000230209 | 2000-07-31 | ||
| PCT/JP2001/006363 WO2002010167A1 (en) | 2000-07-31 | 2001-07-24 | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03000861A true MXPA03000861A (es) | 2004-04-05 |
Family
ID=18723200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03000861A MXPA03000861A (es) | 2000-07-31 | 2001-07-24 | Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6962921B2 (es) |
| EP (1) | EP1306378A4 (es) |
| KR (1) | KR100829297B1 (es) |
| CN (1) | CN1247578C (es) |
| AU (1) | AU7278701A (es) |
| BR (1) | BR0112881A (es) |
| CA (1) | CA2416706C (es) |
| CZ (1) | CZ2003234A3 (es) |
| HK (1) | HK1054231A1 (es) |
| HU (1) | HUP0303714A3 (es) |
| IL (1) | IL154049A0 (es) |
| MX (1) | MXPA03000861A (es) |
| NO (1) | NO20030474L (es) |
| NZ (1) | NZ523812A (es) |
| PL (1) | PL363870A1 (es) |
| RU (1) | RU2277096C2 (es) |
| SK (1) | SK1292003A3 (es) |
| WO (1) | WO2002010167A1 (es) |
| ZA (1) | ZA200300549B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7760101B2 (en) * | 2008-06-20 | 2010-07-20 | Kimberly-Clark Worldwide, Inc. | Method of reducing sensor corrosion in absorbent articles |
| ES2626246T3 (es) * | 2009-09-09 | 2017-07-24 | Sumitomo Dainippon Pharma Co., Ltd. | Derivado de 8-oxodihidropurina |
| US20140301947A1 (en) | 2011-06-06 | 2014-10-09 | Imperial Innovations Limited | Methods to predict binding affinity of tspo imaging agents to tspo |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453428A (en) * | 1991-02-14 | 1995-09-26 | The Mount Sinai School Of Medicine Of The City Of New York | Method and composition for the treatment of apathy-amotivation syndrome |
| AU2295792A (en) * | 1991-06-26 | 1993-01-25 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| GB9208492D0 (en) * | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| US5212195A (en) * | 1992-05-13 | 1993-05-18 | Syntex (U.S.A.) Inc. | Substituted indole antagonists derivatives which are angiotensin II |
| EP0882727B9 (en) | 1996-07-03 | 2005-06-15 | Sumitomo Pharmaceuticals Company, Limited | Novel purine derivatives |
| ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| ATE300947T1 (de) * | 1998-12-18 | 2005-08-15 | Scios Inc | Behandlung von erkrankungen mit zystenbildung |
| US6342495B1 (en) * | 1998-12-18 | 2002-01-29 | Scios, Inc. | Agonists and antagonists of peripheral-type benzodiazepine receptors |
| JP3814125B2 (ja) * | 1999-06-02 | 2006-08-23 | 大日本住友製薬株式会社 | ２−アリール−８−オキソジヒドロプリン誘導体からなる医薬 |
-
2001
- 2001-07-24 US US10/343,453 patent/US6962921B2/en not_active Expired - Fee Related
- 2001-07-24 NZ NZ523812A patent/NZ523812A/en unknown
- 2001-07-24 CN CNB018163742A patent/CN1247578C/zh not_active Expired - Fee Related
- 2001-07-24 HK HK03106435.7A patent/HK1054231A1/en unknown
- 2001-07-24 EP EP01951985A patent/EP1306378A4/en active Pending
- 2001-07-24 IL IL15404901A patent/IL154049A0/xx unknown
- 2001-07-24 RU RU2003105827/04A patent/RU2277096C2/ru not_active IP Right Cessation
- 2001-07-24 CZ CZ2003234A patent/CZ2003234A3/cs unknown
- 2001-07-24 KR KR1020037001365A patent/KR100829297B1/ko not_active Expired - Fee Related
- 2001-07-24 BR BR0112881-7A patent/BR0112881A/pt not_active IP Right Cessation
- 2001-07-24 PL PL01363870A patent/PL363870A1/xx not_active Application Discontinuation
- 2001-07-24 WO PCT/JP2001/006363 patent/WO2002010167A1/ja not_active Ceased
- 2001-07-24 SK SK129-2003A patent/SK1292003A3/sk unknown
- 2001-07-24 CA CA002416706A patent/CA2416706C/en not_active Expired - Fee Related
- 2001-07-24 AU AU7278701A patent/AU7278701A/xx not_active Withdrawn
- 2001-07-24 HU HU0303714A patent/HUP0303714A3/hu unknown
- 2001-07-24 MX MXPA03000861A patent/MXPA03000861A/es active IP Right Grant
-
2003
- 2003-01-21 ZA ZA200300549A patent/ZA200300549B/en unknown
- 2003-01-30 NO NO20030474A patent/NO20030474L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6962921B2 (en) | 2005-11-08 |
| CZ2003234A3 (cs) | 2003-05-14 |
| EP1306378A1 (en) | 2003-05-02 |
| PL363870A1 (en) | 2004-11-29 |
| KR100829297B1 (ko) | 2008-05-13 |
| HUP0303714A2 (hu) | 2004-03-01 |
| CN1466587A (zh) | 2004-01-07 |
| CA2416706C (en) | 2009-04-07 |
| RU2277096C2 (ru) | 2006-05-27 |
| US20030166667A1 (en) | 2003-09-04 |
| NO20030474D0 (no) | 2003-01-30 |
| CN1247578C (zh) | 2006-03-29 |
| HK1054231A1 (en) | 2003-11-21 |
| WO2002010167A1 (en) | 2002-02-07 |
| NZ523812A (en) | 2004-07-30 |
| EP1306378A4 (en) | 2005-02-09 |
| BR0112881A (pt) | 2003-07-01 |
| ZA200300549B (en) | 2003-08-19 |
| NO20030474L (no) | 2003-03-27 |
| HUP0303714A3 (en) | 2007-03-28 |
| CA2416706A1 (en) | 2002-02-07 |
| SK1292003A3 (en) | 2003-08-05 |
| AU7278701A (en) | 2002-02-13 |
| IL154049A0 (en) | 2003-07-31 |
| KR20030019634A (ko) | 2003-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04006322A (es) | Derivados de 6-fluorobiciclo[3.1.0]hexano. | |
| TW330202B (en) | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals | |
| NO950297D0 (no) | Prolinamidderivater | |
| CA2333703A1 (en) | Isothiazole derivatives useful as anticancer agents | |
| WO2001009103A3 (en) | Imidazole antiproliferative agents | |
| WO1998035951A3 (en) | New aminopiperazine derivatives | |
| WO1999000373A8 (en) | Benzimidazole derivatives | |
| EP1182193A4 (en) | REMEDIES FOR NEUROGENIC PAIN | |
| NO20052683L (no) | Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| EP1142881A4 (en) | POLY (ADP-RIBOSE) POLYMERASE INHIBITORS CONSISTING OF PYRIMIDINE DERIVATIVES | |
| WO2002032901A3 (en) | Bridged piperazine derivatives | |
| EA200100916A1 (ru) | Лекарственное средство, содержащее производное сульфопиранозилацилглицерина | |
| ES2093091T3 (es) | Derivado de glutation. | |
| KR0165901B1 (en) | 4-[(2-BENZOTHIAZOLYL) METHYLAMINO]-Ñß-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINE ETHANOL | |
| EP1813270A4 (en) | PROTEIN INHIBITORS OF THE HSP90 FAMILY | |
| EP1134219A4 (en) | AMINOMETHYLPYRROLIDINE DERIVATIVES SUBSTITUTED BY CYCLOALKYLES | |
| DE69734678D1 (de) | 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung | |
| EP1103543A4 (en) | NOVEL UREA DERIVATIVES CONTAINING NITROGENIC AROMATIC HETEROCYCLES | |
| WO2000044722A8 (en) | Chondrongenesis promotors and indolin-2-one derivatives | |
| MXPA03000861A (es) | Remedios para la demencia que contienen derivados de 2-abril-8-oxodihidropurina como ingrediente activo. | |
| HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
| CA2127067A1 (fr) | Derives d'acide phosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP1219296A4 (en) | MEANS TO INHIBIT SEBUM PRODUCTION | |
| AU2983792A (en) | Diaminomethyleneamino substituted substituted phenyl thiazoles | |
| EP1074545A4 (en) | ISOCHINOLINE SULPHONAMIDE DERIVATIVES AND MEDICINES CONTAINING IT AS AN ACTIVE INGREDIENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration |